oxybutynin has been researched along with Alloxan Diabetes in 16 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypoglycemia is a serious and potentially fatal complication experienced by people with insulin-dependent diabetes." | 1.72 | Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. ( GhavamiNejad, A; Giacca, A; Liu, JF; Lu, B; Mirzaie, S; Pereira, S; Samarikhalaj, M; Wu, XY; Zhou, L, 2022) |
| " Here we present a novel intraepidermal delivery technology (delivered site at epidermis layer, <150 μm) by combining skin pretreatment with short microneedles (<150 μm in length) and iontophoresis transdermal patch (enhanced transport via electrical field) that can provide a continuous basal dose and on-demand bolus dosing for mealtime insulin needs." | 1.38 | Simultaneous basal-bolus delivery of fast-acting insulin and its significance in diabetes management. ( Gao, Y; Li, F; Qin, G; Qiu, Y; Wu, Y; Xu, B; Zhang, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, J | 3 |
| Wang, J | 2 |
| Zhang, Y | 1 |
| Chen, G | 2 |
| Mao, W | 1 |
| Ye, Y | 1 |
| Kahkoska, AR | 3 |
| Buse, JB | 3 |
| Langer, R | 1 |
| Gu, Z | 3 |
| Wang, Z | 1 |
| Li, H | 1 |
| Wu, V | 1 |
| Zeng, Y | 1 |
| Wen, D | 1 |
| Miedema, JR | 1 |
| Li, Y | 1 |
| Yang, J | 2 |
| Zheng, Y | 1 |
| Ye, R | 2 |
| Liu, B | 2 |
| Huang, Y | 1 |
| Zhou, W | 1 |
| Jiang, L | 2 |
| GhavamiNejad, A | 2 |
| Lu, B | 2 |
| Samarikhalaj, M | 1 |
| Liu, JF | 1 |
| Mirzaie, S | 1 |
| Pereira, S | 1 |
| Zhou, L | 2 |
| Giacca, A | 2 |
| Wu, XY | 2 |
| Seong, KY | 1 |
| Seo, MS | 1 |
| Hwang, DY | 1 |
| O'Cearbhaill, ED | 1 |
| Sreenan, S | 1 |
| Karp, JM | 1 |
| Yang, SY | 1 |
| Sibiya, N | 3 |
| Ngubane, P | 2 |
| Mabandla, M | 3 |
| Kim, YS | 1 |
| Sung, DK | 1 |
| Kong, WH | 1 |
| Kim, H | 1 |
| Hahn, SK | 1 |
| Chen, Z | 1 |
| Li, J | 2 |
| Lin, Y | 1 |
| Gao, J | 1 |
| Ren, L | 1 |
| Lam, L | 1 |
| Hadebe, SI | 2 |
| Ngubane, PS | 2 |
| Serumula, MR | 2 |
| Musabayane, CT | 2 |
| Hu, X | 1 |
| Qian, C | 1 |
| Lu, Y | 1 |
| Xie, Z | 1 |
| Jing, X | 1 |
| Qin, G | 2 |
| Gao, Y | 2 |
| Wu, Y | 2 |
| Zhang, S | 2 |
| Qiu, Y | 2 |
| Li, F | 1 |
| Xu, B | 2 |
16 other studies available for oxybutynin and Alloxan Diabetes
| Article | Year |
|---|---|
Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Delivery Syste | 2020 |
Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Melli | 2020 |
Iontophoresis-driven porous microneedle array patch for active transdermal drug delivery.
Topics: Administration, Cutaneous; Animals; Diabetes Mellitus, Experimental; Drug Delivery Systems; Humans; | 2021 |
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Sy | 2022 |
A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Topics: Acrylates; Administration, Cutaneous; Animals; Biological Availability; Blood Glucose; Diabetes Mell | 2017 |
The Ameliorative Effect of Pectin-Insulin Patch On Renal Injury in Streptozotocin-Induced Diabetic Rats.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ins | 2017 |
Synergistic effects of hyaluronate - epidermal growth factor conjugate patch on chronic wound healing.
Topics: Administration, Topical; Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Foot; Drug Li | 2018 |
Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
Topics: Administration, Cutaneous; Animals; Diabetes Mellitus, Experimental; Drug Delivery Systems; Equipmen | 2018 |
The pectin-insulin patch application prevents the onset of peripheral neuropathy-like symptoms in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Hand Strength | 2018 |
Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
Topics: Animals; Blood Glucose; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2019 |
Transdermal delivery of insulin by amidated pectin hydrogel matrix patch in streptozotocin-induced diabetic rats: effects on some selected metabolic parameters.
Topics: Administration, Cutaneous; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glycogen; Hypogl | 2014 |
The effects of transdermal insulin treatment of streptozotocin-induced diabetic rats on kidney function and renal expression of glucose transporters.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Monitoring; Glucose; Hypoglyc | 2015 |
H
Topics: Animals; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Glucose; Glucose Oxi | 2017 |
Cardioprotective effects of pectin-insulin patch in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiotonic Agents; Diabetes Mellitus, E | 2017 |
Simultaneous basal-bolus delivery of fast-acting insulin and its significance in diabetes management.
Topics: Administration, Cutaneous; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Insu | 2012 |
Novel lyophilized hydrogel patches for convenient and effective administration of microneedle-mediated insulin delivery.
Topics: Acrylamides; Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; F | 2012 |